
Esters and Derivatives
Found 42242 products of "Esters and Derivatives"
Etofenamate Myristate
CAS:Controlled ProductFormula:C32H44F3NO5Color and Shape:NeatMolecular weight:579.694-(2,3-Dichlorophenyl)-2,6-dimethyl-3,5-pyridinedicarboxylic Acid Methyl (1-oxobutoxy)methyl Ester
CAS:Controlled ProductFormula:C21H21Cl2NO6Color and Shape:NeatMolecular weight:454.3Etofenamate Palmitate
CAS:Controlled ProductFormula:C34H48F3NO5Color and Shape:NeatMolecular weight:607.74Fenofibrate impurity G
CAS:Fenofibrate impurity G is a drug product that is synthesized from natural sources and is not chemically modified. It has the CAS number 217636-48-1. Fenofibrate impurity G is an analytical standard in the field of drug development and pharmacopoeia. It can be used as a metabolite or impurity standard in research and development, HPLC standard, or as a niche product for pharmaceutical companies. Fenofibrate impurity G can be synthesized to create new chemical entities.Formula:C24H27ClO6Purity:Min. 95%Molecular weight:446.92 g/molGuaifenesin EP Impurity B
CAS:Guaifenesin (GP) is a phenylpropanoid that is used as an expectorant and cough suppressant. Guaifenesin EP Impurity B is a by-product of the synthesis of guaifenesin, which can be removed by preparative chromatography. It has been shown to catalyze reactions with acidic substrates and has the ability to form magnesium complexes. The reaction mechanism for guaifenesin EP Impurity B is not well understood, but it has been shown that hydrotalcite and magnesium oxide can remove GP from solution. This impurity also reacts with zirconium to form zirconium oxide, which can be removed by techniques such as mesoporous silica gel chromatography.Formula:C10H14O4Purity:Min. 95%Molecular weight:198.22 g/mol(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone
CAS:(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone is a drug product that is Custom synthesized to meet the requirements of pharmacopoeia, analytical, and drug development. It has been studied for its metabolism and toxicity profile in animals. This compound is a metabolite of chlorpheniramine, which is used as an antihistamine. Metabolites of this compound have also been identified in humans. The CAS Registry Number for this compound is 154356-96-4.Formula:C16H15ClO2Purity:Min. 95%Molecular weight:274.74 g/molN-(3-Trifluoromethylphenyl)-phenylamine
CAS:N-(3-Trifluoromethylphenyl)-phenylamine is a research and development drug product that is used as an analytical impurity standard. It has a CAS number of 101-23-5 and is classified under the trade name 3TFPPA. The chemical formula for N-(3-Trifluoromethylphenyl)-phenylamine is C12H8F3NO. This compound can be synthesized from phenylamine, 3-trifluoromethylaniline, and hydrochloric acid. The molecular weight of this compound is 197.19 g/mol, which falls within the range of 195 to 200 g/mol. N-(3-Trifluoromethylphenyl)-phenylamine can be found in the following pharmacopoeia: USP (United States Pharmacopeia), EP (European Pharmacopoeia), JP (Japanese Pharmacopeia), BP
Formula:C13H10F3NPurity:Min. 95%Molecular weight:237.22 g/mol3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone
CAS:3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone is an impurity in the drug product, N-{3-[4-(4-chlorobenzoyl)phenoxy]-2-butenyl}acetamide. It can be used as an analytical reference standard for determining the presence of impurities in pharmaceutical products. 3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone is not a natural component of the API and is typically synthesized with high purity. This compound has been shown to be metabolized by human liver microsomes and rat lung microsomes. The metabolic pathways are unknown but may include oxidation, hydrolysis, or conjugation reactions.Formula:C17H15ClO3Purity:Min. 95%Molecular weight:302.75 g/mol1,4-Bis(2,3,4-trimethoxybenzyl)piperazine
CAS:Controlled Product1,4-Bis(2,3,4-trimethoxybenzyl)piperazine (1,4BTMP) is a piperazine derivative that has been shown to have inotropic properties. 1,4BTMP appears to increase the force of contraction of the heart muscle by increasing intracellular calcium levels. This drug may also be useful in the treatment of ventricular fibrillation and other arrhythmias. It has been shown that 1,4BTMP protects against lipid peroxidation induced by hydrogen chloride and hydrochloric acid in isolated rat hearts. In addition, this compound has been shown to inhibit creatine kinase activity and reduce lipid peroxide formation.
Formula:C24H34O6Purity:Min. 95%Molecular weight:418.52 g/mol4-[(2,3,4-Trimethoxyphenyl)methyl]-1-piperazinecarboxylic acid ethyl ester
CAS:4-[(2,3,4-Trimethoxyphenyl)methyl]-1-piperazinecarboxylic acid ethyl ester is an impurity standard for HPLC. It is a white or off-white solid that is soluble in organic solvents. The compound has been shown to be a metabolite of the drug product, and can also be found as an impurity in the API. 4-[(2,3,4-Trimethoxyphenyl)methyl]-1-piperazinecarboxylic acid ethyl ester can be synthesized from 2,3,4-trimethoxybenzoic acid and 1-(2-chloroethyl)piperazine.
Formula:C17H26N2O5Purity:Min. 95%Molecular weight:338.4 g/molButamirate
CAS:Butamirate is a cough suppressant, it works by acting centrally through the receptors in the brainstem.Formula:C18H29NO3Purity:98%Color and Shape:SolidMolecular weight:307.43Esterastin
CAS:Esterastin is an Inhibitor of esterases.Formula:C28H46N2O6Color and Shape:SolidMolecular weight:506.67Triethylene glycol flufenamate
CAS:Etofenamate impurity
Formula:C20H22F3NO5Purity:Min. 95%Color and Shape:Clear LiquidMolecular weight:413.39 g/molRef: 4Z-I-1928
Discontinued productRef: 4Z-M-154003
Discontinued productRef: 4Z-M-207001
Discontinued productMethyl 4-Acetamido-5-Bromo-2-Methoxybenzoate
CAS:Formula:C11H12BrNO4Color and Shape:White To Off-White SolidMolecular weight:302.13Ref: 4Z-M-481
Discontinued productRef: 4Z-A-301003
Discontinued productRef: 4Z-P-112022
Discontinued product



